Search Results 3141-3150 of 25676 for oral

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

2. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

3. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   Background regimen for UC may include oral 5-aminosalicylate (5-ASA), oral corticosteroids, budesonide multi-matrix system (MMX), probiotics, azathioprine ...

4. Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures after Endotherapy - Mayo Clinic

   Hypothesis: Oral budesonide prevents esophageal stricture formation in patients who underwent radical endoscopic mucosal resection (EMR) or endoscopic ...

5. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   ... (oral paclitaxel or HM30181A) or pembrolizumab - Currently taking following ... - An oral medication with a narrow therapeutic index known to be a P-gp ...

6. Mayo Clinic Q and A: Increasing incidence of throat cancer related to HPV

   Two strains of HPV cause 70% of all cervical cancer. HPV infections also can lead to other genital and anal cancers in females, as well as penile and anal ...

7. Robert W. DePompolo, M.D. - Doctors and Medical Staff - Mayo Clinic

   Oral Board ExaminerResidency Program, Department of Physical Medicine and Rehabilitation, Mayo Medical School.  . MemberMayo Foundation for Medical ...

8. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

9. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

   Diuretics and oral rehydration solutions will be required to be stable for ≥4 weeks prior to baseline evaluations and remain stable during the study.

10. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    ... oral antihypertensives as so judged by the treating physician; Known dihydropyrimidine dehydrogenase (DPD) deficiency; Impairment of GI function or GI disease ...